-+ 0.00%
-+ 0.00%
-+ 0.00%

HELUS PHARMA : BARCLAYS INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $35

Reuters·09/21/2026 09:58:35

Please log in to view news